User profiles for Donald P. Bottaro

Donald Bottaro

National Cancer Institute
Verified email at helix.nih.gov
Cited by 22995

Identification of the Hepatocyte Growth Factor Receptor As the c-met Proto-Oncogene Product

DP Bottaro, JS Rubin, DL Faletto, AML Chan… - Science, 1991 - science.org
Hepatocyte growth factor (HGF) is a plasminogen-like protein thought to be a humoral
mediator of liver regeneration. A 145-kilodalton tyrosyl phosphoprotein observed in rapid …

Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2B

M Santoro, F Carlomagno, A Romano, DP Bottaro… - Science, 1995 - science.org
Multiple endocrine neoplasia types 2A and 2B (MEN2A and MEN2B) and familial medullary
thyroid carcinoma are dominantly inherited cancer syndromes. All three syndromes are …

Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene.

T Miki, DP Bottaro, TP Fleming… - Proceedings of the …, 1992 - National Acad Sciences
Expression cDNA cloning and structural analysis of the human keratinocyte growth factor
receptor (KGFR) revealed identity with one of the fibroblast growth factor (FGF) receptors …

[PDF][PDF] The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma

…, EA Gibb, R Akbani, R Beroukhim, DP Bottaro… - Cell reports, 2018 - cell.com
Renal cell carcinoma (RCC) is not a single disease, but several histologically defined cancers
with different genetic drivers, clinical courses, and therapeutic responses. The current …

Targeting the c-Met signaling pathway in cancer

B Peruzzi, DP Bottaro - Clinical cancer research, 2006 - AACR
On binding to the cell surface receptor tyrosine kinase (TK) known as c-Met, hepatocyte growth
factor (HGF) stimulates mitogenesis, motogenesis, and morphogenesis in a wide range …

[HTML][HTML] Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma

…, PS Meltzer, MJ Merino, DP Bottaro… - Journal of Clinical …, 2013 - ncbi.nlm.nih.gov
Purpose Foretinib is an oral multikinase inhibitor targeting MET, VEGF, RON, AXL, and TIE-2
receptors. Activating mutations or amplifications in MET have been described in patients …

[HTML][HTML] Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling

…, V Anest, WG Taylor, K Muraiso, DP Bottaro… - Journal of Biological …, 2000 - ASBMB
Secreted Frizzled-related protein-1 (sFRP-1) contains a cysteine-rich domain homologous
to the putative Wnt-binding site of Frizzleds. To facilitate the biochemical and biological …

[HTML][HTML] Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling

…, AN Soria, WH Burgess, T Miki, DP Bottaro… - Journal of biological …, 1999 - ASBMB
In an effort to isolate novel growth factors, we identified a human protein, designated Sk, that
co-eluted with Neuregulin during chromatographic separation of conditioned medium from …

[PDF][PDF] Multilevel genomics-based taxonomy of renal cell carcinoma

…, V Reuter, CS Shelley, BA Kaipparettu, DP Bottaro… - Cell reports, 2016 - cell.com
On the basis of multidimensional and comprehensive molecular characterization (including
DNA methalylation and copy number, RNA, and protein expression), we classified 894 renal …

A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor.

JS Rubin, AML Chan, DP Bottaro… - Proceedings of the …, 1991 - National Acad Sciences
A heparin-binding mitogen was isolated from conditioned medium of human embryonic lung
fibroblasts. It exhibited broad target-cell specificity whose pattern was distinct from that of …